ASCO® 2024 Highlights: Presenter Vignette – Omid Hamid

Dr. Omid Hamid

Omid Hamid

MD

Cedars-Sinai

Abstract# 9507

Phase 1 safety and efficacy of IMC-F106C, a PRAME × CD3 ImmTAC bispecific, in post-checkpoint cutaneous melanoma (CM).